National Heart, Lung, and Blood Institute; Amended Notice of Meeting
---
identifier: "/us/fr/03-26361"
source: "fr"
legal_status: "authoritative_unofficial"
title: "National Heart, Lung, and Blood Institute; Amended Notice of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "03-26361"
section_name: "National Heart, Lung, and Blood Institute; Amended Notice of Meeting"
positive_law: false
currency: "2003-10-20"
last_updated: "2003-10-20"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "03-26361"
document_type: "notice"
publication_date: "2003-10-20"
agencies:
- "Health and Human Services Department"
- "National Institutes of Health"
fr_citation: "68 FR 59945"
fr_volume: 68
---
# National Heart, Lung, and Blood Institute; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the Clinical Trials Review Committee, June 23, 2003, 8 a.m. to June 24, 2003, 5 p.m., Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814 which was published in the *Federal Register* on March 26, 2003, 68 FR 14671-14672.
The meeting will be held June 23, 2003 for one day only. The meeting is closed to the public.
Dated: October 9, 2003.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.